FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study

Philip N Newsome, Magali Sasso, Jonathan J Deeks, Angelo Paredes, Jérôme Boursier, Wah-Kheong Chan, Yusuf Yilmaz, Sébastien Czernichow, Ming-Hua Zheng, Vincent Wai-Sun Wong, Michael Allison, Emmanuel Tsochatzis, Quentin M Anstee, David A Sheridan, Peter J Eddowes, Indra N Guha, Jeremy F Cobbold, Valérie Paradis, Pierre Bedossa, Véronique Miette, Céline Fournier-Poizat, Laurent Sandrin, Stephen A Harrison

Open source

DOI
10.1016/s2468-1253(19)30383-8
Published
2020-04
Container
The Lancet Gastroenterology & Hepatology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2468-1253-19-30383-8,
  title = {FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study},
  author = {Philip N Newsome and Magali Sasso and Jonathan J Deeks and Angelo Paredes and Jérôme Boursier and Wah-Kheong Chan and Yusuf Yilmaz and Sébastien Czernichow and Ming-Hua Zheng and Vincent Wai-Sun Wong and Michael Allison and Emmanuel Tsochatzis and Quentin M Anstee and David A Sheridan and Peter J Eddowes and Indra N Guha and Jeremy F Cobbold and Valérie Paradis and Pierre Bedossa and Véronique Miette and Céline Fournier-Poizat and Laurent Sandrin and Stephen A Harrison},
  year = {2020},
  journal = {The Lancet Gastroenterology \& Hepatology},
  doi = {10.1016/s2468-1253(19)30383-8},
  url = {https://doi.org/10.1016/s2468-1253(19)30383-8}
}

RIS

TY  - JOUR
TI  - FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
AU  - Philip N Newsome
AU  - Magali Sasso
AU  - Jonathan J Deeks
AU  - Angelo Paredes
AU  - Jérôme Boursier
AU  - Wah-Kheong Chan
AU  - Yusuf Yilmaz
AU  - Sébastien Czernichow
AU  - Ming-Hua Zheng
AU  - Vincent Wai-Sun Wong
AU  - Michael Allison
AU  - Emmanuel Tsochatzis
AU  - Quentin M Anstee
AU  - David A Sheridan
AU  - Peter J Eddowes
AU  - Indra N Guha
AU  - Jeremy F Cobbold
AU  - Valérie Paradis
AU  - Pierre Bedossa
AU  - Véronique Miette
AU  - Céline Fournier-Poizat
AU  - Laurent Sandrin
AU  - Stephen A Harrison
PY  - 2020
JO  - The Lancet Gastroenterology & Hepatology
DO  - 10.1016/s2468-1253(19)30383-8
UR  - https://doi.org/10.1016/s2468-1253(19)30383-8
ER  - 

APA

Newsome, P. N., Sasso, M., Deeks, J. J., Paredes, A., Boursier, J., Chan, W., Yilmaz, Y., Czernichow, S., Zheng, M., Wong, V. W., Allison, M., Tsochatzis, E., Anstee, Q. M., Sheridan, D. A., Eddowes, P. J., Guha, I. N., Cobbold, J. F., Paradis, V., Bedossa, P., Miette, V., Fournier-Poizat, C., Sandrin, L., & Harrison, S. A. (2020). FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(19)30383-8

Source records